NOCIWay ™

If you are interested in a pain profile for your Discovery leads, but are restricted to the use of mice, then you should consider NOCIWay^TM, a unique in vivo screening tool that has been reconfigured for use in this species.

Advantages include low compound requirements, more rapid turnaround (2 weeks) and increased cost-effectiveness.

NOCIWay^TM simultaneously explores the activity of your compound in 5 fully validated pain models / tests across 3 different pain areas:

– Acute & tonic pain
– Inflammatory pain
– Visceral pain
– plus a behavioral toxicity assessment using the modified Irwin grid

The analgesic fingerprint provided by NOCIWay^TM can be your first result generated
in vivo, one that can serve as a guide for further development.